5-carboxamidotryptamine has been researched along with sb 258719 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, AM; Collin, LL; Ellis, CE; Forbes, IT; Gittins, SA; Gloger, I; Hagan, J; Middlemiss, DN; Riley, G; Thomas, DR | 1 |
| Glennon, RA | 1 |
| Intagliata, S; Lacivita, E; Leopoldo, M; Modica, MN; Pittalà, V; Romeo, G; Salerno, L | 1 |
1 review(s) available for 5-carboxamidotryptamine and sb 258719
| Article | Year |
|---|---|
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Topics: Animals; Humans; Ligands; Receptors, Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
2 other study(ies) available for 5-carboxamidotryptamine and sb 258719
| Article | Year |
|---|---|
Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719.
Topics: Adenylyl Cyclases; Cell Line; Cloning, Molecular; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Piperidines; Protein Binding; Receptors, Serotonin; Recombinant Proteins; Serotonin Antagonists; Sulfonamides | 1998 |
Structure-Activity Relationships and Therapeutic Potentials of 5-HT
Topics: Animals; Antidepressive Agents; Central Nervous System Diseases; Humans; Ligands; Neurodevelopmental Disorders; Receptors, Serotonin; Structure-Activity Relationship | 2018 |